Corcept Therapeutics | CORT - Market Capitalization


Corcept Therapeutics reported $9.6B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
ANI Pharmaceuticals USD 1.75B 24M Mar/2026
Ardelyx USD 1.48B 63M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 125.74M 431.39M Jul/2026
Corcept Therapeutics USD 4.32B 654M Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
J&J USD 595.26B 16.1B Jul/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 12.82B 11.96B Jul/2026
Novartis USD 307.76B 15.54B Mar/2026
Novartis USD 319.89B 31.63B Jul/2026
Pacira USD 915M 149M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
TG Therapeutics USD 5.31B 572M Mar/2026